Europe Tele-epilepsy Market Size, Share & Trends Analysis Report By Patient (Adult and Pediatric), By End Use (Healthcare Consumers, Hospitals Providers, and Payers), By Component), By Country and Growth Forecast, 2024 - 2031
Europe Tele-epilepsy Market Size, Share & Trends Analysis Report By Patient (Adult and Pediatric), By End Use (Healthcare Consumers, Hospitals Providers, and Payers), By Component), By Country and Growth Forecast, 2024 - 2031
The Europe Tele-epilepsy Market would witness market growth of 15.2% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Tele-epilepsy Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $85.9 million by 2031. The UK market is exhibiting a CAGR of 14.2% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.1% during (2024 - 2031).
At the heart of tele-epilepsy is the capacity to connect patients with epilepsy specialists through secure, high-definition video consultations, real-time data sharing, and advanced digital health tools. These devices enable healthcare clinicians to monitor seizure activity, adjust medications, and deliver prompt interventions without necessitating patients to travel long distances or wait for appointments.
For patients who are vulnerable to frequent, unpredictable seizures, this remote access is a significant improvement over traditional care, as it offers a level of flexibility and responsiveness that was previously unavailable. Tele-epilepsy also promotes a sense of continuity in care, as patients can maintain consistent communication with their providers and adhere to follow-up schedules that are frequently challenging to accomplish through in-person visits alone.
France has seen increased demand for tele-epilepsy, largely fueled by its government’s efforts to reduce healthcare disparities in rural and underserved areas. The French Ministry of Health has actively supported telemedicine through the “Ma Santé 2022” plan, which aims to provide remote care options for patients in areas with limited access to specialists. As part of this initiative, the government has funded healthcare providers to establish tele-epilepsy services, ensuring that epilepsy patients can access specialized care regardless of their location. The French health insurance system also covers telemedicine consultations, supporting patient adoption. France’s emphasis on reducing regional healthcare gaps and improving accessibility has positioned tele-epilepsy as essential for nationwide neurological care. Hence, the regional market will experience expedited growth in the coming years.
Based on Patient, the market is segmented into Adult and Pediatric. Based on End Use, the market is segmented into Healthcare Consumers, Hospitals Providers, and Payers. Based on Component, the market is segmented into Software, Hardware, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
Shimmer Research Ltd.
Emotiv Inc.
CortiCare, Inc.
SEVARO
Tele Specialists
Real Time Tele-Epilepsy Consultants
ScienceSoft USA Corporation
Zeto, Inc.
TeleEEG
Epitel, Inc.
Europe Tele-epilepsy Market Report Segmentation
By Patient
Adult
Pediatric
By End Use
Healthcare Consumers
Hospitals Providers
Payers
By Component
Software
Hardware
Services
By Country
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tele-epilepsy Market, by Patient
1.4.2 Europe Tele-epilepsy Market, by End Use
1.4.3 Europe Tele-epilepsy Market, by Component
1.4.4 Europe Tele-epilepsy Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Tele-epilepsy Market by Patient
4.1 Europe Adult Market by Country
4.2 Europe Pediatric Market by Country
Chapter 5. Europe Tele-epilepsy Market by End Use
5.1 Europe Healthcare Consumers Market by Country
5.2 Europe Hospitals Providers Market by Country
5.3 Europe Payers Market by Country
Chapter 6. Europe Tele-epilepsy Market by Component
6.1 Europe Software Market by Country
6.2 Europe Hardware Market by Country
6.3 Europe Services Market by Country
Chapter 7. Europe Tele-epilepsy Market by Country
7.1 Germany Tele-epilepsy Market
7.1.1 Germany Tele-epilepsy Market by Patient
7.1.2 Germany Tele-epilepsy Market by End Use
7.1.3 Germany Tele-epilepsy Market by Component
7.2 UK Tele-epilepsy Market
7.2.1 UK Tele-epilepsy Market by Patient
7.2.2 UK Tele-epilepsy Market by End Use
7.2.3 UK Tele-epilepsy Market by Component
7.3 France Tele-epilepsy Market
7.3.1 France Tele-epilepsy Market by Patient
7.3.2 France Tele-epilepsy Market by End Use
7.3.3 France Tele-epilepsy Market by Component
7.4 Russia Tele-epilepsy Market
7.4.1 Russia Tele-epilepsy Market by Patient
7.4.2 Russia Tele-epilepsy Market by End Use
7.4.3 Russia Tele-epilepsy Market by Component
7.5 Spain Tele-epilepsy Market
7.5.1 Spain Tele-epilepsy Market by Patient
7.5.2 Spain Tele-epilepsy Market by End Use
7.5.3 Spain Tele-epilepsy Market by Component
7.6 Italy Tele-epilepsy Market
7.6.1 Italy Tele-epilepsy Market by Patient
7.6.2 Italy Tele-epilepsy Market by End Use
7.6.3 Italy Tele-epilepsy Market by Component
7.7 Rest of Europe Tele-epilepsy Market
7.7.1 Rest of Europe Tele-epilepsy Market by Patient
7.7.2 Rest of Europe Tele-epilepsy Market by End Use
7.7.2.1.1 Rest of Europe Tele-epilepsy Market by Component